126 related articles for article (PubMed ID: 30658858)
21. Phase-change contrast agents for imaging and therapy.
Sheeran PS; Dayton PA
Curr Pharm Des; 2012; 18(15):2152-65. PubMed ID: 22352770
[TBL] [Abstract][Full Text] [Related]
22. Effects of microchannel confinement on acoustic vaporisation of ultrasound phase change contrast agents.
Lin S; Zhang G; Leow CH; Tang MX
Phys Med Biol; 2017 Aug; 62(17):6884-6898. PubMed ID: 28718774
[TBL] [Abstract][Full Text] [Related]
23. Imaging of vaporised sub-micron phase change contrast agents with high frame rate ultrasound and optics.
Lin S; Zhang G; Jamburidze A; Chee M; Leow CH; Garbin V; Tang MX
Phys Med Biol; 2018 Mar; 63(6):065002. PubMed ID: 29384498
[TBL] [Abstract][Full Text] [Related]
24. Transient acoustic vaporization signatures unique to low boiling point phase change contrast agents enable super-resolution ultrasound imaging without spatiotemporal filtering.
DeRuiter RM; Markley EN; Rojas JD; Pinton GF; Dayton PA
AIP Adv; 2020 Oct; 10(10):105124. PubMed ID: 33094029
[TBL] [Abstract][Full Text] [Related]
25. Intracellular delivery and ultrasonic activation of folate receptor-targeted phase-change contrast agents in breast cancer cells in vitro.
Marshalek JP; Sheeran PS; Ingram P; Dayton PA; Witte RS; Matsunaga TO
J Control Release; 2016 Dec; 243():69-77. PubMed ID: 27686582
[TBL] [Abstract][Full Text] [Related]
26. Precision manufacture of phase-change perfluorocarbon droplets using microfluidics.
Martz TD; Sheeran PS; Bardin D; Lee AP; Dayton PA
Ultrasound Med Biol; 2011 Nov; 37(11):1952-7. PubMed ID: 21963036
[TBL] [Abstract][Full Text] [Related]
27. The role of inertial cavitation in acoustic droplet vaporization.
Fabiilli ML; Haworth KJ; Fakhri NH; Kripfgans OD; Carson PL; Fowlkes JB
IEEE Trans Ultrason Ferroelectr Freq Control; 2009 May; 56(5):1006-17. PubMed ID: 19473917
[TBL] [Abstract][Full Text] [Related]
28. The efficiency and stability of bubble formation by acoustic vaporization of submicron perfluorocarbon droplets.
Reznik N; Shpak O; Gelderblom EC; Williams R; de Jong N; Versluis M; Burns PN
Ultrasonics; 2013 Sep; 53(7):1368-76. PubMed ID: 23652262
[TBL] [Abstract][Full Text] [Related]
29. Phase change events of volatile liquid perfluorocarbon contrast agents produce unique acoustic signatures.
Sheeran PS; Matsunaga TO; Dayton PA
Phys Med Biol; 2014 Jan; 59(2):379-401. PubMed ID: 24351961
[TBL] [Abstract][Full Text] [Related]
30. Selective intracellular delivery of perfluorocarbon nanodroplets for cytotoxicity threshold reduction on ultrasound-induced vaporization.
Ishijima A; Yamaguchi S; Azuma T; Kobayashi E; Shibasaki Y; Nagamune T; Sakuma I
Cancer Rep (Hoboken); 2019 Aug; 2(4):e1165. PubMed ID: 32721118
[TBL] [Abstract][Full Text] [Related]
31. Thermal activation of superheated lipid-coated perfluorocarbon drops.
Mountford PA; Thomas AN; Borden MA
Langmuir; 2015 Apr; 31(16):4627-34. PubMed ID: 25853278
[TBL] [Abstract][Full Text] [Related]
32. Phase-transitional Fe
Wang R; Zhou Y; Zhang P; Chen Y; Gao W; Xu J; Chen H; Cai X; Zhang K; Li P; Wang Z; Hu B; Ying T; Zheng Y
Theranostics; 2017; 7(4):846-854. PubMed ID: 28382158
[TBL] [Abstract][Full Text] [Related]
33. An evaluation of the sonoporation potential of low-boiling point phase-change ultrasound contrast agents in vitro.
Fix SM; Novell A; Yun Y; Dayton PA; Arena CB
J Ther Ultrasound; 2017; 5():7. PubMed ID: 28127427
[TBL] [Abstract][Full Text] [Related]
34. Intensified and controllable vaporization of phase-changeable nanodroplets induced by simultaneous exposure of laser and ultrasound.
Zhang Q; Yang Y; Xue H; Zhang H; Yuan Z; Shen Y; Guo X; Fan Z; Wu X; Zhang D; Tu J
Ultrason Sonochem; 2023 Mar; 94():106312. PubMed ID: 36731283
[TBL] [Abstract][Full Text] [Related]
35. Toward ultrasound molecular imaging with phase-change contrast agents: an in vitro proof of principle.
Sheeran PS; Streeter JE; Mullin LB; Matsunaga TO; Dayton PA
Ultrasound Med Biol; 2013 May; 39(5):893-902. PubMed ID: 23453380
[TBL] [Abstract][Full Text] [Related]
36. Spatial control of gas bubbles and their effects on acoustic fields.
Lo AH; Kripfgans OD; Carson PL; Fowlkes JB
Ultrasound Med Biol; 2006 Jan; 32(1):95-106. PubMed ID: 16364801
[TBL] [Abstract][Full Text] [Related]
37. Characterization of acoustic droplet vaporization for control of bubble generation under flow conditions.
Kang ST; Huang YL; Yeh CK
Ultrasound Med Biol; 2014 Mar; 40(3):551-61. PubMed ID: 24433748
[TBL] [Abstract][Full Text] [Related]
38. Acoustic Characterization and Enhanced Ultrasound Imaging of Long-Circulating Lipid-Coated Microbubbles.
Li H; Yang Y; Zhang M; Yin L; Tu J; Guo X; Zhang D
J Ultrasound Med; 2018 May; 37(5):1243-1256. PubMed ID: 29127707
[TBL] [Abstract][Full Text] [Related]
39. Imaging the Activation of Low-Boiling-Point Phase-Change Contrast Agents in the Presence of Tissue Motion Using Ultrafast Inter-frame Activation Ultrasound Imaging.
Jing B; Brown ME; Davis ME; Lindsey BD
Ultrasound Med Biol; 2020 Jun; 46(6):1474-1489. PubMed ID: 32143861
[TBL] [Abstract][Full Text] [Related]
40. Nanoparticles Formed by Acoustic Destruction of Microbubbles and Their Utilization for Imaging and Effects on Therapy by High Intensity Focused Ultrasound.
Blum NT; Yildirim A; Chattaraj R; Goodwin AP
Theranostics; 2017; 7(3):694-702. PubMed ID: 28255360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
